C4 Therapeutics, Inc.: cash_and_restricted_cash
| Value | {"amount": 164021000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2021-09-30) |
| Status | current |
| Entity | C4 Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9a8e40bd-97ac-46e6-8d32-9b7d7181dc64
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-056223Retrieved: 2026-08-19T17:06:02.697479+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001662579/cash-and-restricted-cash/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9a8e40bd-97ac-46e6-8d32-9b7d7181dc64
History
- no predecessors — first report